Tag: integrated care
Latest articles
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
CMA formally concludes fludrocortisone investigation
The Competition and Markets Authority (CMA) has formally concluded its fludrocortison investigation and found that three pharmaceutical companies took part in an illegal arrangement...
MHRA response to Independent Medicines and Medical Devices Safety Review
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to the Independent Medicines and Medical Devices Safety Review. In its response, the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations
The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
European Commission approves extended Invokana ® (canagliflozin) indication
The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...